U.S. flag

An official website of the United States government

Filters

See more specimen types...

Other countries

Results: 1 to 20 of 31

Tests names and labsConditionsGenes, analytes, and microbesMethods

RightMed Mental Health test

OneOme, LLC
United States
615
  • D Deletion/duplication analysis
  • T Targeted variant analysis

Genomind Pharmacogenetic Report

Genomind, Inc. Genomind, Inc
United States
1427
  • T Targeted variant analysis

GeneSight Psychotropic

Assurex Health, Inc.
United States
614
  • D Deletion/duplication analysis
  • T Targeted variant analysis

nP.v3

Tempus AI - ATL Tempus AI
United States
413
  • T Targeted variant analysis

NEURODEVELOPMENTpgx

Eugenomic S.L.
Spain
116
  • T Targeted variant analysis

PGx - Neurology Panel

Genesys Diagnostics Genesys Diagnostics, Inc.
United States
17
  • T Targeted variant analysis

PGx - Pain Management Panel

Genesys Diagnostics Genesys Diagnostics, Inc.
United States
112
  • T Targeted variant analysis

PGx - Comprehensive Panel

Genesys Diagnostics Genesys Diagnostics, Inc.
United States
120
  • T Targeted variant analysis

PGx - Mental Health Panel

Genesys Diagnostics Genesys Diagnostics, Inc.
United States
110
  • T Targeted variant analysis

CYP1A2 Gene Cytochrome P450 deficiency NGS Genetic DNA Test

DNA Labs India
India
11
  • S Mutation scanning of the entire coding region

Gravity Pharmacogenetics Comprehensive Profile

Gravity Diagnostics
United States
8617
  • T Targeted variant analysis

CARDIOpgx

Eugenomic S.L.
Spain
116
  • T Targeted variant analysis

PSICOpgx

Eugenomic S.L.
Spain
779
  • T Targeted variant analysis

GLOBALpgx

Eugenomic S.L.
Spain
14521
  • T Targeted variant analysis

PGx-NP (Neuro-Psychiatry)

SPMED CO., LTD Step forward Personalized Medicine
South Korea
5126
  • T Targeted variant analysis

Polypharmacy Comprehensive Panel

Labcorp Genetics (formerly Invitae) LabCorp
United States
3324
  • D Deletion/duplication analysis
  • T Targeted variant analysis

NeuroIDgenetix

AltheaDx/Castle Biosciences
United States
211
  • D Deletion/duplication analysis
  • T Targeted variant analysis

Susceptibility to adverse reaction due to clozapine (sequence analysis of CYP1A2 gene)

CGC Genetics Unilabs
Portugal
11
  • C Sequence analysis of the entire coding region

Basic Pharmacogenetics

Genologica Medica
Spain
46
  • C Sequence analysis of the entire coding region

CYP1A2 mutation analysis - 2 polymorphisms CYP1A2*1C and *1F

Genetiks Genetic Diagnosis Center Genetic Diseases Evaluation Center
Turkey
11
  • E Sequence analysis of select exons

Results: 1 to 20 of 31

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.